P
Picodya
Re-Innovating Point of Care Diagnostics
About Picodya
Picodya is a pioneering company in the diagnostics industry, specializing in advanced point-of-care (POC) testing solutions. The company operates in the healthcare market, serving medical professionals, clinics, and hospitals that require quick and accurate diagnostic results. Picodya's core product, the B-Matrix platform, allows for multiple tests to be conducted simultaneously, significantly reducing the time and cost associated with traditional single-test models. The business model is centered around the sale and distribution of its diagnostic platforms and consumables, generating revenue through both direct sales and partnerships with healthcare providers. By leveraging cutting-edge technology and a strong focus on quality control and compliance, Picodya aims to revolutionize the diagnostics landscape.
Source: Dealroom company dataAt a glance
- Founded
- 2018
- Headquarters
- Rehovot, Israel
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
South Israel Bridging Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Picodya on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Picodya on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.